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Health policies in Africa are shifting towards integrated care services for chronic conditions, 31 
but in parts of Africa robust evidence on effectiveness is limited. We assessed the integration 32 
of vertical health services for HIV, diabetes and hypertension provided in a feasibility study 33 
within five health facilities in Uganda.  34 
From November 2018 to January 2020, we conducted a series of three in-depth interviews with 35 
31, 29 and 24 service users attending the integrated clinics within Kampala and Wakiso 36 
districts.  Ten health care workers were interviewed twice during the same period. Interviews 37 
were conducted in Luganda, translated into English, and analysed thematically using the 38 
concepts of availability, affordability and acceptability.  39 
All participants reported shortages of diabetes and hypertension drugs and diagnostic 40 
equipment prior to the establishment of the integrated clinics. These shortages were mostly 41 
addressed in the integrated clinics through a drugs buffer. Integrated clinics did not affect 42 
provision of anti-retroviral therapy. The cost of transport reduced because of fewer clinic visits 43 
after the establishment of the integrated clinic. Health care workers reported that the main cause 44 
of non-adherence among users with diabetes and hypertension was poverty.  Participants with 45 
diabetes and hypertension reported they could not afford private clinical investigations and 46 
purchase of drugs prior to establishment of the integrated clinics. The strengthening of drug 47 
supply for non-communicable conditions in the integrated clinics was welcomed. Most 48 
participants observed that the integrated clinic reduced feelings of stigma for those living with 49 
HIV. Sharing the clinic afforded privacy about an individual’s condition, and users were 50 
comfortable with the waiting room sitting arrangement.  51 
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We found that integrating non-communicable disease and HIV care had benefits for all users. 52 
Integrated care could be an effective model of care if service users have access to a reliable 53 
supply of basic medicines for both HIV and non-communicable disease conditions.  54 
 55 
Keywords: Integrated care, HIV, diabetes, hypertension, East Africa 56 
  57 
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Background  58 
Non-communicable diseases (NCDs), specifically hypertension and diabetes, now account for 59 
much of the global disease burden. The population of much of sub-Saharan Africa is 60 
experiencing a burden of infections and NCDs (1), albeit in the midst of social, political and 61 
economic uncertainties which influence health, disease and mortality patterns (2). In East 62 
Africa, for example, a WHO STEPS (3) survey in south west Uganda and north west Tanzania 63 
reported diabetes and HIV prevalence to be 4% and 5% respectively, while hypertension 64 
prevalence ranged between 25% -30% (4). Similarly, in Kenya the 2015 STEPS survey gave 65 
an age-standardised prevalence of hypertension of 24.5% with diabetes at 2.4% (5), and HIV 66 
prevalence in 2020 of 4.2% among adults aged 15-49 years (6).  67 
The increasing availability of, and access to, HIV care and anti-retroviral treatment has enabled 68 
people living with HIV to live healthy lives into older age in most of the world (7-9). People 69 
living with HIV and who are on anti-retroviral treatment (ART) can experience a range of NCD 70 
comorbidities, partly as a result of living longer when people become more prone to a range of 71 
non-communicable diseases (10).  However, in addition, HIV infection can increase the risk of 72 
some conditions, including cancer, and some ART drugs can increase the likelihood of heart 73 
disease and diabetes (11-14).  Therefore, this population is a part of a growing cohort in need 74 
of NCD care, requiring NCD services to be integrated into the care provided by HIV 75 
programmes (4, 15-18).  76 
The World Health Organization (WHO), advocates for integration of health service delivery as 77 
the most logical way to provide health care (19). The WHO defines integration as: `the 78 
organization and management of the health services so that people get the care they need, when 79 
they need it in ways that are user friendly, achieve the desired results and provide value for 80 
money’ (19). In line with the WHO integration, we defined and operationalised integration as: 81 
‘a one stop centre’ providing healthcare to the community and accessible to people with any 82 
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chronic condition. Integration requires a well-trained work force, drug supplies, diagnostic 83 
resources and clinic structural improvements to support the successful treatment of a range of 84 
chronic conditions (13, 20, 21).  85 
An integrated chronic care model was introduced in South Africa in 2011 to provide HIV and 86 
other chronic condition care in combined clinics (22).  The findings of feasibility studies 87 
showed that the model reduced service duplication and the frequency of patient visits in 88 
selected primary health facilities in South Africa (23-25).  Similar improvements were also 89 
found in HIV-clinic settings in both Malawi (26) and Nigeria (27).  The integration of NCD 90 
care for people living with HIV has been highlighted as a need in Nigeria, Zambia, Swaziland 91 
and Kenya (28-30) as well as in Uganda (31-33).   92 
Integration not only requires the implementation of supportive policies but also training for 93 
health care workers and infrastructure development, to enable changes in care delivery in 94 
public health systems (34-36).  Such provision is required for people with a range of chronic 95 
conditions to enable them to access integrated care in a single location, whether or not one of 96 
their conditions is HIV.  In Uganda, health provision for HIV and NCDs is usually offered 97 
separately through diseases specific clinics, and NCD care is less well funded than HIV care 98 
(37). In addition, there is still a limited understanding of service user and provider perceptions 99 
and experiences of accessing, receiving and providing integrated HIV and NCD care with 100 
which to inform the establishment and scaling up of integrated services. To respond to this 101 
need, we conducted a longitudinal study, using qualitative methods, to examine the perceptions 102 
and experiences of receiving and providing integrated HIV/NCD care in selected health 103 
facilities in Kampala and Wakiso districts in Uganda. Ultimately, we sought to understand 104 
better the integration process from diverse perspectives and experiences in order to contribute 105 




METHODOLOGY  108 
Study background  109 
This study was nested within a larger feasibility study entitled Management Of Chronic 110 
Conditions in Africa (MOCCA) which from August 2018 to December 2019 was conducted in 111 
five health facilities (four government and one private not for profit clinic) in Kampala and 112 
Wakiso districts in Uganda. The aim of MOCCA was to develop and evaluate a model of 113 
integrated HIV, hypertension and diabetes care where all health facility services were to be 114 
provided in a single location as a ‘one stop centre’. To facilitate this, the participating health 115 
facilities established integrated HIV/NCD clinics.  Thus, patients with any one or more of the 116 
target conditions – HIV, diabetes or hypertension – were managed in a single clinic.  This 117 
meant that people presenting with HIV, diabetes or hypertension all had the same waiting areas, 118 
were seen by the same clinical staff and used the same counselling, laboratory and pharmacy 119 
services. 120 
Health care workers at the participating facilities were trained to ensure provision of quality 121 
and standardised care for all three conditions in an integrated manner. This was supported by 122 
the provision of a buffer supply of diabetes and hypertension drugs and laboratory supplies in 123 
the event of drug shortages in the Ugandan Government pharmaceutical supply chain. The 124 
MOCCA study did not supply buffer drugs for HIV treatment because the supply of these drugs 125 
through the Government system was dependable. The study also facilitated the identical file 126 
colouring for patients with all conditions in the HIV/NCD integrated clinic.  127 
Conceptual Framework 128 
A number of theoretical and conceptual frameworks have been applied in studies of integrated 129 
care systems which focus on concepts such as satisfaction and acceptability (38-41) We utilised 130 
the conceptual framework developed and described by Thiede, Akweongo (42) and McIntyre, 131 
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Thiede (43) on access to health care, since `access’ was a prominent concept arising from the 132 
data. Thiede, Akweongo (42) describe access as `the opportunity to use health services, 133 
reflecting an understanding that there is a set of circumstances that allows for the use of 134 
appropriate health services’ (p104).  They proceed to divide access into three dimensions: 135 
availability (physical access); affordability (financial access) and acceptability (cultural 136 
access). Cleary, Birch (44) further developed this framework to examine access to ART in 137 
South Africa, and defined the three dimensions in the following way: availability as the `fit 138 
between a patient’ needs and the type, place and time of series provided; affordability is the 139 
`fit between the costs of utilising a service and the patient’s ability to pay the associated costs’; 140 
and acceptability as the fit between health care provider and the patient’ attitudes and 141 
expectations of each other (p.142).  We summarise these dimensions in the figure below: 142 
Figure 1 Dimensions of access 143 
Availability Affordability Acceptability 
Travel time to health facility 
Waiting time at health 
facility 
Expenditure to reach health 
facility 
Expenditure at health facility 
(drugs, diagnostics, 
consultation) 
Expenditure on self-care 
(cost of drugs and treatment 
outside of the facility) 
Perceptions of health care 
facility staff attitudes and 
ability to manage a range of 
conditions 
 
Health facility cleanliness/ 
length of queues/ general 
efficiency 
Adapted from Cleary, Birch (44) 144 
We used this framework in order to examine the dimensions of access to integrated HIV and 145 
NCD care in a Ugandan context.     146 
8 
 
Study setting 147 
The study took place in clinics at different levels in the Government system in Uganda.  The 148 
five facilities included in the study were categorised as follows, and identified in this paper by 149 
letter:  150 
A and B: Health centre IVs which have an inpatient capacity of 50-100 inpatient beds overseen 151 
by a medical doctor and offer the following services: general minor surgery, laboratory 152 
investigations, diagnosis and management of uncomplicated acute and stable chronic 153 
conditions including diabetes, hypertension and HIV. At these centres people with stable 154 
chronic conditions including diabetes, hypertension and HIV are treated (patients with 155 
complicated conditions are referred to district hospitals). Both facilities are in Wakiso District. 156 
C and D: Health centre IIIs which are run by a clinician or a mid-wife  and offer the following 157 
the services: diagnosis and management  of uncomplicated chronic conditions including 158 
diabetes, hypertension and HIV, while referring complicated cases to health centre IVs.  Both 159 
health facilities are in Kampala District.  160 
E: Private not for profit facility which specialised in HIV care delivery and the treatment of 161 
uncomplicated diabetes and or hypertension experienced by people living with HIV who 162 
attended the facility (37). This facility is in Kampala District. 163 
ll health facilities offered HIV and NCD care either in standalone clinics or in an outpatient 164 
department prior to MOCCA.  The facilities were selected purposely to represent different 165 
health facility levels and ownership with a mix of urban and peri-urban characteristics.  166 
The Medical Research Council /Uganda Virus Research Institute (MRC/UVRI) and the 167 
London School of Hygiene and Tropical Medicine (LSHTM), Uganda Research Unit in 168 
collaboration with the Liverpool School of Tropical Medicine (LSTM) and the Uganda 169 
Ministry of Health designed and implemented the feasibility study.  170 
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Ethical considerations 171 
The study received ethical clearance from TASO Research Ethics Committee and Uganda 172 
National Council for Science and Technology (UNCST) in Uganda (Reference TASO 173 
REC/015/18-UG-REC-009).  174 
Permission to conduct the study was also sought from the relevant district and health facility 175 
authorities. Participants were enrolled following informed consent while privacy, 176 
confidentiality, anonymity, and voluntary participation were adhered throughout the study. 177 
Sample selection 178 
Study participants were selected from health facility service users (hereafter referred to as 179 
`users’) enrolled or receiving care from the HIV, hypertension and diabetes clinics and health 180 
care workers (doctors, medical assistants and nurses, hereafter referred to as HCW) at the 181 
participating facilities. Users were purposively recruited at enrolment into HIV/NCD 182 
integrated care study clinic during the months of March and April 2019. We aimed to recruit 183 
five users with either HIV, hypertension, diabetes or a combination of these conditions from 184 
each participating facility. Out of the five, we recruited two who had a combination of either 185 
HIV with hypertension or diabetes or had hypertension and diabetes. The three other users 186 
recruited were to have been diagnosed with one of the conditions namely HIV, diabetes or 187 
hypertension. The focus for recruitment was the condition and a combination of conditions 188 
rather than age or sex. We recruited/sampled additional individuals because we anticipated loss 189 
to follow up. By the end of the recruitment period, a total of 31 users had been recruited into 190 
the study. Two HCWs were purposively selected from each site (nurses, other clinicians and 191 
in-charges of the clinics) at the beginning of the study to take part in provider interviews. The 192 
study aimed to recruit HCWs engaged in HIV and NCD care delivery. In total ten HCWs were 193 
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recruited. The person in charge of each facility supported the selection of user participants and 194 
the two HCWs from each facility.   195 
Data collection 196 
Data collection was undertaken from November 2018 to February 2020. The users were 197 
interviewed after their clinic visit on each occasion, so were recruited sequentially across the 198 
time period of recruitment when they visited the clinic. The first phase of data collection was 199 
prior to the establishment of the HIV/NCD integrated clinic (March–April 2019). The second 200 
phase with users was two to eight weeks after enrolment (June-July 2019). The third and final 201 
phase of data collection with the users occurred after nine months of recruitment, at the end of 202 
the integrated clinic feasibility study (January –February 2020). 203 
HCWs had two rounds of interviews. The first was carried out prior to the establishment of the 204 
integrated clinic between May–June 2019. The second round was November 2019-January 205 
2020 at the end of the integrated clinic follow up time.  206 
Interviews were used to investigate users’ perspectives prior to the establishment of the NCD 207 
integrated clinic, soon after its establishment and at the end of the nine months follow up 208 
attending the NCD integrated clinic. The same technique explored HCWs’ perspective prior to 209 
establishment of the integrated clinic and at the end of the attending the integrated NCD clinic. 210 
User and the HCW interviews were supported by clinic level observations. 211 
Observations of day-to-day practice in each facility, to observe waiting time, room and service 212 
access procedures were undertaken before other data collection began, and at two further time 213 
points. Observations took place in November 2018 prior to the establishment of the integrated 214 
clinic at the participating sites, then in June 2019 and finally November 2019 (S1 tools).  215 
At the first round of interviews, users were asked about the services they expected to be 216 
provided with at the HIV/NCD integrated clinic (S1 tools). Subsequent interviews explored the 217 
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experiences attending the HIV/NCD integrated clinic. In brief, the phase two and three 218 
interview guide covered; patient demographics, health conditions for which care was sought, 219 
health seeking since the HIV/NCD integrated care establishment, procedure followed while 220 
seeking integrated HIV/NCD care, quality of services received, comfort with the sitting 221 
arrangement at the HIV/NCD integrated clinic and appropriateness of the HIV/NCD integrated 222 
clinic care. Additional questions included: cost of accessing integrated HIV/NCD care, 223 
freedom of entry, discussion and movement around the health facility among others (S1 tools).  224 
The HCWs’ interview guide explored conditions their health facilities treated, types of 225 
HIV/NCD services offered, what HCWs did individually and at an institutional level to ensure 226 
provision of user-friendly services. Other topics explored included: changes in the management 227 
of HIV, diabetes and hypertension in the previous six months, what had to be done to ensure 228 
user-friendly service provision at individual/institution levels.  HCWs were also asked about 229 
patient attitudes and perceptions on the NCD integrated clinic (S1 tools). The final HCW 230 
interview, explored changes introduced in the HIV and NCD care delivery in the previous six 231 
months, HCW thoughts and opinions on what would be integrated care delivery, benefits and 232 
challenges; HCWs’ satisfaction with the integrated care delivery;  user views about integrated 233 
services, and what needed to be done to ensure increased demand for integrated HIV and NCD 234 
care (S1 tools). 235 
Interview data collection was supported by observations which documented changes at the 236 
clinic levels and were used to inform the implementing team of any required adaptations. 237 
Observations investigated how services were provided in practice in standalone clinics (pre-238 
phase) and were used to identify strengths, weaknesses and lessons learnt from the integrated 239 
NCD clinic.  Baseline observations investigated experiences of NCD care delivery in the 240 
standalone disease specific clinics while subsequent data collection covered the experiences of 241 
the integrated NCD clinics.  242 
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Data management  243 
All interviews were conducted by trained and experienced social science interviewers in a 244 
private place at each clinic. All interviews were face to face and audio-recorded after obtaining 245 
consent from the study participant. Interviews with users were conducted in Luganda, the main 246 
local language in the study area while those with HCWs were conducted in English. Interview 247 
transcription was done verbatim and later translated into English. Each interviewer proof-read 248 
their transcripts to ensure completeness and accuracy. The first author reviewed the transcripts 249 
throughout the course of the study to ensure interview content and format. Where gaps were 250 
identified in the transcripts, the audio recordings were listened to check the reason for the gap 251 
and to confirm the correctness of the transcription. Final transcripts were kept on a password 252 
protected study computer organised in a study folder with sub folders for each data category.  253 
The data were backed up on a secure server.  254 
Data analysis 255 
The first author read all the transcripts several times carefully to fully understand the material.. 256 
Through this process, data patterns were observed and emerging themes were identified, 257 
shared, discussed and agreed with the MCH, EHS,SJ and JS. The first author grouped the 258 
emerging themes and patterns according to the constructs of the access conceptual framework 259 
described above to develop the coding framework. . The coding framework was discussed and 260 
agreed upon by DB, MCH, EHS, IK, BMJ, JRK and JS. The first author manually coded all 261 
the data in a way that allowed comparison for differences and similarities at different data 262 
collection points using deductive and inductive processes. Illustrative quotes in the participants 263 
own words were extracted from the interviews and are presented in this paper (45). Data from 264 
users, health care providers and observations were triangulated to increase the richness and 265 
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trustworthiness of the findings. The entire analysis process involved back and forth discussions 266 
between the DB, MCH and JS.    267 
Our findings presented in this paper are grouped by the three dimensions of access: availability, 268 
affordability and acceptability.  We have grouped the themes derived from the data during 269 
analysis under each of these headings, following the example of Cleary, Birch (44), having 270 
adapted their framework for our study. 271 
Figure 2. Dimensions of access to integrated and non-integrated care services 272 
Availability Affordability Acceptability 
Types of service available 
 





Advantages of having 




 to reach health facility 
 at health facility (drugs, 
diagnostics) 
 on items to support self- 
care (e.g. food) 
Advantages of affordable 
care 
Perceptions of type of health 
care facility 
 impact on levels of 
stigma  
 HCW / user relations 
 
Efficiency of services: 
 number of visits 
 length of waiting time/ 
comfort of seating 
arrangement  
 273 
To provide background information on the people who took part in the study, we commence 274 






The 31 users had a mean age of 45 years (range of 23-72 years) and most (22 out of 31) were 279 
women. Slightly more than half were married, educated up to secondary level and earned a 280 
living through informal businesses. Most users had hypertension and diabetes (Table 1). HCWs 281 
had a mean age of 36 (range 28–51) years, most were women (six), married and educated up 282 
to the tertiary level (Table 2).  283 
Table 1. User study profile participants 284 
Variable Categories Phase I Phase II Phase III 
Sex     
 Male (%)  9     (29) 7 (24) 5 (21) 
 Female  22    (71) 22 (76) 19 (79) 
Age (years)     






 Range   23 – 72 23 – 72 24 – 72 
Education level     
 No education    3   (10)      2 (7) 2 (8) 
 Primary  10   (32) 10 (34) 7 (30) 
 Secondary    16 (52) 15 (52) 13 (54) 
 Tertiary    2    (6) 2 (7) 2 (8) 
Marital status     
 Married  17 (55) 17 (58) 15 (62) 
 Separated/divorced  5   (16) 4 (14) 3 (13) 





    
 Business/informal 18 (58) 16 (55) 13 (54) 
 Formal  3 (10) 3 (10) 3 (13) 
 Unemployed 10 (32) 10 (35) 8 (33) 
Disease condition     
 Hypertension 10 (32) 8 (28) 5 (21) 
 Diabetes 8 (27) 8 (28) 6 (25) 
 HIV 7 (22) 7 (24) 7 (29) 
 Multi morbidity 6 (19) 6 (20) 6 (25) 
 285 
Table 2. Health care worker profile study participants 286 
Variable Categories Phase I Phase II 
Sex    
 Male (%)  4     (40) 3 (33) 
 Female  6    (60) 6 (67) 
Age (years)    
 Mean (SD)  36 (37)  36 (38) 
 
 Range   28 - 51 28 – 51 
Education level    
 Tertiary  6 (60)   6 (67) 
 University 4 (40) 3 (33) 
Marital status    
16 
 
 Married  7 (70) 6 (67) 
 Single  3 (30) 3 (33) 
 287 
We now present the findings on the three dimensions from our conceptual framework, 288 
availability, affordability and acceptability in turn, and divided between `before integration’ 289 
and `after integration’ for each dimension. 290 
 291 
Availability 292 
Type of services available before the establishment of the integrated HIV/NCD clinics. 293 
All users reported that the health facilities provided HIV, diabetes and hypertension care prior 294 
to the establishment of the integrated HIV/NCD clinic.  HIV care was similar in all the 295 
participating health facilities and included: pre and post-test counselling, anti-retroviral therapy 296 
initiation and drug refills, coupled with adherence counselling. Neither HCWs nor users 297 
reported experiencing HIV drug shortages or problems accessing diagnostic testing materials.  298 
 “Each time, I have come to the facility for HIV drugs refill, I get all the drugs 299 
assigned [prescribed]. There has never been a day I found when there were no 300 
drugs’’, (user #7, a 42-year-old male with NCD and HIV at facility D, first round 301 
of interviews). 302 
Although the participating public facilities provided diabetic and hypertensive care together in 303 
an NCD clinic, the NCD care provision was often subject to drugs and/or reagents shortages 304 
coupled with missing or malfunctioning diagnostic equipment.  305 
“It is the diabetes and hypertension drugs that are often unavailable’’, (user #29, a 306 
63-year-old male with NCD and HIV at facility A, first round of interviews).  307 
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However, this was not the case in the private facility (E), where no user reported experiencing 308 
drug shortages, or laboratory reagents missing or malfunctioning diagnostic equipment for HIV 309 
or NCD conditions.  310 
The users attending all health facilities prior to integration were familiar with the services 311 
available to them for their treatment needs.    312 
‘They give us health education sessions every time we visit the facility. These 313 
health education sessions are given by both men and women and usually we are 314 
seated in a mixed up [more than one NCD] arrangement. Then I go to see the ART 315 
doctor who reviews my files and after that is when I come to get drugs”, (user #4, 316 
a 60-year-old female with NCD and HIV at facility B, first round of interviews).  317 
Treatment services for the HIV and NCDs were located in different places in the facility, 318 
if users needed treatment for co-morbidities. 319 
 320 
HIV/NCD service availability after the establishment of the HIV/NCD integrated clinic 321 
All HCWs reported that the establishment of the integrated clinic boosted the availability of 322 
diabetes and hypertension care, noting that HIV care availability was already sufficient.  They 323 
further explained that shortly before the establishment of the integrated clinics, their facilities 324 
were supplied with new functional diagnostic equipment for diabetes and hypertension, such 325 
blood pressure machines and dip sticks. They added that a diabetes and hypertension drug 326 
buffer stock was also established to cover for diabetic and hypertensive drug shortages.  These 327 
augmented services were, as we explain above, provided as part of MOCCA. It is not surprising 328 
therefore, that it was during the second round of interviews the HCWs reported improved 329 
diabetic and hypertensive drug availability.  In Facility D two clinical staff, both women aged 330 
about 30 years, explained how the care provision had been transformed: 331 
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 “We have got medical equipment like blood pressure (BP) machines from the 332 
project.  The project provided four BP machines, batteries and glucometers. 333 
Without these, we wouldn’t be able to test the patients without testing strips. We 334 
used to treat diabetes and hypertension before the integration but not as intensively 335 
as we do now. The project also provided some drugs for hypertension and diabetes 336 
and this has increased drug availability for patients”, (HCW participant #8, second 337 
round of interviews).  338 
“Previously there was a challenge with drug availability as drugs would always be 339 
out of stock, but after integration, drug availability improved greatly and this built 340 
confidence among the patients and even the retention levels became higher”, 341 
(HCW participant #2,  second round of interviews). 342 
Almost all of the diabetes and hypertension users at the public health facilities also reported 343 
that drug shortages of drugs for those conditions had become rare since the establishment of 344 
the integrated clinic.  345 
 “It [integration] was good because I used to come to the facility and they could 346 
still prescribe the drugs for me and ask me to go and buy them from elsewhere. I 347 
now get free care and treatment as well now, unlike back then.”, (user #23, a 50-348 
year-old female with NCD at facility C, second round of interviews).   349 
However, as MOCCA was coming to an end (when the third round of interviews took place) 350 
there were a few users with diabetes and hypertension who reported that drug shortages had 351 
slowly started creeping back.  352 
 “I don’t pay any cost for health care services at this facility except [now] I only 353 
get one type of the prescribed drugs and I buy the other”, (user #14, a 36-year-old 354 
female with NCD at facility D, third round of interviews). 355 
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The participants who were accessing integrated care from facility E, the private not for profit 356 
facility, did not report experiencing any NCD drug shortages at any time during the follow up 357 
period. However, users of this clinic did report that the establishment of the integrated clinic 358 
marked the start of active screening of diabetes and hypertension among the people living with 359 
HIV attending that facility.  Those users described how active screening for diabetes and 360 
hypertension for them accompanied the opening up of the facility to users accessing non- HIV-361 
care.  362 
“...because of the integration, I can now be screened and treated for diabetes and 363 
hypertension at my HIV clinic but previously I have been going to private clinics 364 
to test for those diseases”, (user #11, a 31-year-old female with HIV at facility E, 365 
third round of interviews). 366 
 367 
Challenges with types of service before establishment of integrated HIV/NCD clinic  368 
As the users of facility E note above, prior to establishment of HIV/NCD integrated clinic, that 369 
facility provided limited diabetes and hypertension care only to users in receipt of HIV-care. 370 
Complicated diabetes and hypertension cases at their facility were referred to the neighbouring 371 
national referral hospital.  372 
In the public health facilities the HCWs reported during the first round of interviews that the 373 
availability of diabetic and hypertensive care was limited due to drugs and diagnostic material 374 
shortages, and faulty or missing diagnostic equipment.  375 
 “… there are some challenges when the facility runs out of stock for some 376 
diagnostic instruments such as testing kits and sometimes it could take almost three 377 
months without testing clients. There are times when a blood pressure machine also 378 
breaks down and this could go on for even a week. This makes the clinic miss out 379 
on some very important measurements that would have been captured…. when you 380 
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ask the client to go and do the test out there, some clients are not in position to...”, 381 
(HCW participant #6, a 29-year-old male laboratory technologist, at facility C, first 382 
round of interviews).  383 
Users in the public health facilities reported that often, when they sought care for diabetes and 384 
hypertension, they were given prescriptions and advised to go and buy the drugs from private 385 
pharmacies.  386 
“When there are no insulin drugs at the facility, there are at times when they 387 
prescribe for me drugs and ask me to go and buy some drugs when they don’t have 388 
them in stock” (user #19, a 57-year-old female with NCD at facility B, first round 389 
of interviews).  390 
However, in one of the facilities (A), the HCWs had initiated a diabetes and hypertension club 391 
where users contributed some money towards their refill visits. The diabetes and hypertension 392 
users at this facility explained this money was used to buy themselves buffer drugs/testing 393 
materials to counter drug and reagent shortages.  394 
“… I pay Shs 30,000shs [US Dollars 8] every six months in the [user] club and this 395 
money is used for buying testing strips and drugs in case of stock outs. This method 396 
just started recently in the previous years we used to go without drugs when the 397 
government drugs were out of stock”, (user #16, a 48-year-old female with NCD 398 
at facility A, first round of interviews).  399 
The HCWs’ role was only to guide on where to buy the drugs for the buffer stock financed and 400 
managed by the users themselves.   401 
 402 
Affordability  403 
Expenditure to reach health facility before the establishment of the HIV/NCD integrated clinic 404 
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Regardless of the disease condition, most users reported that prior to the establishment of the 405 
HIV/NCD integrated clinic their inability to afford transport to and from the health facilities 406 
hindered their access to and retention in HIV, diabetes and hypertension care. The challenge of 407 
finding money to support a visit to the clinic was a recurrent theme throughout  the study. This 408 
was unsurprising since the majority of users continued to attend the facility they used prior to 409 
integration.  410 
 “the distance is long and I use 2,000 shillings [ ~ one USD] to go to the facility 411 
but I find it hard to get money for transport”, (user #11, a 31-year-old female with 412 
HIV at facility E, first round of interviews).  413 
“I sometimes fail to get transport to the facility for treatment. I came with a boda 414 
boda [motorcycle taxi] which costs me Shs 2000 [ ~ one USD] to come to the health 415 
facility. I am thinking of walking back home in the guise of doing exercise because 416 
I have no money at hand”, (user #26, a 33-year-old male with NCD and HIV at 417 
facility A, second round of interviews).  418 
Some HCWs agreed that transport was a major challenge to accessing health care for all users 419 
in general and was not only limited to HIV, diabetes and hypertension care users.  Lack of 420 
transport was a common reason for people to miss drug refills and clinic appointments.  421 
 “I have a concern some clients miss their appointment and never show up, this is 422 
common for HIV clients. There are some clients of hypertension and diabetes who 423 
do not take these drugs [as being] very important and serious. […] some say they 424 
do not have transport since some clients come from very far”, (HCW participant # 425 
7, a 51-year-old female nursing assistant at facility C, first round of interviews). 426 
A small number of users reported no challenges with transport because they lived close to the 427 
facility where they were accessing care. 428 
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“The facility is not so far from where I stay. The distance is walkable.  I use a boda 429 
boda [motorcycle taxi] if I am late and that would cost me about Shs 2,000 [~ one 430 
USD] but usually I move on foot and that takes me about an hour.” (user #17, a 46-431 
year-old male with HIV at facility C, first round of interviews). 432 
Integration reduced the number of visits users had to make to facilities (as we discuss further 433 
below), which did make accessing care more affordable overall, even if finding funds for a 434 
clinic visit remained challenging. 435 
 436 
Expenditure on drugs, diagnostics and consultations before establishment of the HIV/NCD 437 
integrated clinic  438 
Prior to the establishment of the integrated clinic, diabetes and hypertension users reported an 439 
inability to buy diabetic and hypertensive drugs from private pharmacies. In addition to this, 440 
the diabetes users reported that they could not afford the private clinical investigations that they 441 
needed to have.  442 
 “I couldn’t afford to finance all the required further investigations privately and to 443 
buy all the drug types that I needed. …’’, (user #12, a 54-year-old female with 444 
NCD at facility B, first round of interviews).  445 
Almost all diabetes and hypertension care users attending the integrated clinic reported reduced 446 
requirements to purchase drugs from private pharmacies.  This was observed during the second 447 
and third interviews.  448 
The HCWs agreed that the integrated clinic had helped to make diabetic and hypertensive drugs 449 
available and affordable to the users through buffer stock supplies, although most expressed 450 
concerns about whether this situation would be sustainable.  451 
“I am worried with the fact that what will happen when the project stops, would 452 
there be new files given or would there be drugs always availed? Hypertensive and 453 
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diabetic patients had become so many and yet concentration [of resources] was 454 
always turned to HIV and immunization”. (HCW participant #3, a 49-year-old 455 
male nurse and anaesthetist at facility B, second round of interviews). 456 
As described earlier, the only exception was Facility A which operated a diabetes and 457 
hypertension patient club before establishing the integrated clinic, where they contributed 458 
money which helped to buy drugs in the event of a shortage.  459 
 460 
Expenditure on self-care before establishment of the HIV/NCD integrated clinic 461 
A small number of HCWs reported that diabetes and hypertension users were non-adherent to 462 
the treatment before the HIV/NCD clinic integration, an observation they attributed to poverty 463 
and an inadequate knowledge about their conditions.   464 
 “Stocked drugs are inadequate for the high number of hypertension patients. Even 465 
those for diabetes are not enough. Many of these patients cannot afford to buy from 466 
private pharmacies and they decide to go without medication till when the next 467 
supply comes’’, HCW participants #1, a female nurse, aged 38 years at facility C, 468 
first round of interviews.  469 
However, it was not only a matter of not being able to afford drugs. Some HCWs reported that 470 
hypertensive users were less adherent and skipped drug refill appointments.  471 
‘’I have a concern on how some patients don’t take their drugs religiously. Some 472 
patients miss their appointments and never show up. There were some hypertensive 473 
and diabetic patients who do not take these drugs [as being] very important and 474 
serious’’, (HCW participant #7, a 51-year-old female nursing assistant at facility 475 
C, first round of interviews).  476 
24 
 
Some HIV-care users reported being faced with a shortage of food, which sometimes 477 
obstructed their treatment adherence. Some of these users further explained that they 478 
experienced drug side effects when they took their drugs on an empty stomach.   479 
“I am faced with a challenge of inadequate food as I take my drugs daily. These 480 
drugs require a lot of food, and once I take drugs without food, I become dizzy and 481 
weak”, (user #28, a 53-year-old female with NCD and HIV at facility B, first round 482 
of interviews). 483 
Given that the integrated clinic did not address food insecurity this situation did not change 484 
for such users. 485 
 486 
Expenditure on self-care  after the establishment of the HIV/NCD integrated clinic  487 
 Interestingly, challenges caused by poverty continued in the second and third phases of data 488 
collection.  Indeed, there was an increasing number of HIV and diabetes care users who 489 
reported being faced with food shortages which they said hindered their treatment adherence. 490 
These people explained that this was because they were advised to revise their dietary intake 491 
by the HCWs, which some could not afford to do (because the foods they were advised to take 492 
were more expensive than their usual diet). Some of these users further explained that they 493 
experienced drug side effects when they took their drugs on an empty stomach.   494 
 “Among the challenges that I get while taking my drugs is the absence of food, my 495 
drugs require a lot of food, and once I take drugs without food, I become dizzy, 496 
shiver, become weak and sometimes pass out”, (user #14, a 50-year-old female 497 
with NCD and HIV at facility A, second round of interviews).  498 
The problem of poverty, affecting the ability of some health care users to eat well, persisted 499 





Users views on the acceptability of integrated care before HIV/NCD care integration 503 
Prior to the establishment of the integrated clinic, there were a small number of diabetes and 504 
hypertension service care users who perceived that the integrated clinic could potentially 505 
expose them to tuberculosis (TB) infection, especially if the HIV users were ill with various 506 
opportunistic infections. However, these users expressed the view that if people living with 507 
HIV had linked to care in good time, they would not be sick, and therefore would not pose a 508 
risk.  509 
“…the only problem to the integration would be when HIV patients join while very 510 
sick with so many signs and symptoms [opportunistic infections] like TB 511 
[tuberculosis]…. since a person with TB would definitely infect the other persons 512 
without the disease…. TB patients cough incessantly, and others inhale the germs”. 513 
(user #12, a 54-year-old female with NCD at facility B, third round of interviews).  514 
People with hypertension and diabetes did not openly express their stigma against people living 515 
with HIV sharing a clinic, before integration occurred.  Instead, their concerns focused on the 516 
risk to their own health from being close to people with contagious conditions, like TB. 517 
 518 
HIV/NCD integrated clinic acceptability after the establishment of the integrated clinic 519 
The majority of the HCWs reported that the users’ knowledge about their conditions improved 520 
with the establishment of the integrated clinic. The HCWs attributed the increased user 521 
knowledge to the intensified joint HIV/NCD patient education session that were put in place 522 
after the establishment of the HIV/NCD integrated clinic.  523 
“…the patients awareness about their conditions has improved ever since the 524 
integrated clinic was established because health education is a must at the 525 
integrated clinic every time a patient comes for review or drugs refill. They 526 
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(patients) are taught about what to eat, doing physical exercises, taking their pills 527 
religiously and cautioned against risk factors like alcohol, smoking…”. (HCW 528 
participant #4, a 28-year-old female clinician at facility D, second round of 529 
interviews). 530 
This increased knowledge also helped users to understand conditions others attending the 531 
facility were accessing treatment for. 532 
 533 
Impact of type of service on stigma after HIV/NCD care integration 534 
Prior to HIV/NCD care integration, most of the people living with HIV accessing care reported 535 
that HIV-related stigma had greatly reduced in recent years. They further added that diabetes 536 
and hypertension were not stigmatised conditions.   537 
“I don’t feel any form of stigma when I come to the hospital [facility] for HIV 538 
drugs because all those who come to collect the same drugs are like me. Even 539 
though one pinpointed to[stigmatised]me, it does not make any sense now days 540 
because it is hard to know who is HIV infected and who is not’’, user #22, a 2613-541 
year-old female with HIV at facility B, first round of interviews).  542 
Most HIV care users prior to the integration of HIV/NCD care explained that they enjoyed a 543 
good relationship amongst themselves which helped to minimise HIV related stigma.  544 
‘Sometimes I worry about my life but when I call one of my friends at the facility and they 545 
advise me. My friends at the facility usually tell me not to stress myself and I become strong’’, 546 
user #24, a 23-year-old female with HIV at facility A, first round of interviews.  547 
No HCWs reported observing or expressing stigma towards the HIV and NCD care users prior 548 
to the establishment of the integrated clinic. 549 
 550 
Acceptability of HIV/NCD integrated care after HIV/NCD care integration 551 
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Some users reported that the integrated clinic was acceptable because it had helped to further 552 
reduce stigma, as it was hard to tell what condition a person was being treated for. They 553 
explained that the file colour was identical for all conditions (under MOCCA) and that each 554 
participant consulted the clinician privately, so the person’s reason for seeking treatment was 555 
kept confidential.  The HCW responses showed agreement with this view, because they had 556 
observed the free mixing of the patients at the integrated clinic.  557 
However, in one facility, facility C, registration, health education and dispensing occurred in 558 
the same room. With such an arrangement users could overhear what may be being said to an 559 
individual coming for their appointment or collecting drugs.  560 
 Users of that facility also complained that there could be a long wait to see a clinician.  561 
However, the users learnt to manage this situation. 562 
“I follow the health facility procedure and even ask for help if I get some 563 
challenges…I go to the reception, then from there I enter the room the MOCCA 564 
[integrated clinic] from where they do a blood sugar estimation. I then go to the 565 
laboratory and thereafter I go for medical consultation and finally proceed to the 566 
pharmacy to pick drugs. The place which gives me most challenges is the reception, 567 
because whenever I come late, I find a huge line which I have to follow patiently.  568 
My most useful moment is when I meet the HCWs, they are so supportive’’, (user 569 
#27, a 36-year-old male with NCD at facility D, second round of interviews).  570 
Despite claims of reduced HIV related stigma and efforts to reduce it further, there were  some 571 
young HIV care users who reported being uncomfortable queuing for the integrated services 572 
amongst older people. These young people explained that they suspected the older patients to 573 
suspect them to be infected with HIV, because they were young, since the hypertension and 574 
diabetes were more common among the older people.  575 
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“There is a problem with the youth sitting with the older persons since the older 576 
persons might suspect the youths to be infected with HIV  and this demoralises the 577 
youth when the older persons show it”. (user #24, a 23-year-old female with HIV 578 
at facility A, third round of interviews).  579 
 580 
HCW-user relations before the HIV/NCD integrated clinic establishment  581 
Most of the HIV and NCD users reported that they enjoyed fairly good relationships with their 582 
HCWs prior to the establishment of the HIV/NCD integrated clinic. However, some users said 583 
that there were some HCWs who talked to them rudely and did not  take time to explain to 584 
them. 585 
‘’We have some friendly health workers who take time to find out why you are 586 
missing your drug refill appointments and explain to you that missing one drug 587 
refill is detrimental to one’s health. There are some health workers who just talk to 588 
you in the presence of everyone about how you are doing badly’’, (user #15, a 59-589 
year-old female with HIV at facility B, first round of interviews) 590 
 591 
HCW-patient relationship after the establishment of the HIV/NCD integrated clinic  592 
Most of the users reported that improved HCW –patient relationships made the integrated clinic 593 
acceptable. They explained that HCWs who worked in the integrated clinic talked to them 594 
nicely and sometimes addressed them by their name.   595 
 “The health workers at the integrated clinic treat all the users equally without 596 
discrimination. No one can know the other person’s condition. I feel peace getting 597 
treatment from the integrated clinic”, (user #20, a 49-year-old female with HIV at 598 
facility A, third round of interviews).   599 
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“…there is a good relationship between me as a patient and the health worker. The 600 
medical team makes sure that they politely speak to you in a language that you best 601 
understand, any medical person will show you the love that you need in regard to 602 
the type of work s/he is doing… so that is what happens here”, (user #23, a 50-603 
year-old female with NCD at facility C, second round of interviews).   604 
The users did observe, however, that the HCWs were tough on those who missed their refill 605 
appointments. 606 
HCWs reported that they were trying their best to deliver user friendly health services in the 607 
integrated clinic. They explained that they offered health education to the integrated clinic 608 
attendees on the procedure to access care, and they do this in a friendly way. They added that 609 
all this was an effort to make the integrated clinic acceptable to the participants.  610 
 611 
Efficiency of services of the HIV and NCD care before to HIV/NCD care integration 612 
Almost all the users of the HIV and NCD care services reported that they appreciated the HCW 613 
and facility observation of the, ‘first come, first serve’, principle prior to the HIV/NCD care 614 
integration. The users explained that it was important that they took turns to consult the HCW 615 
privately.  HCW reported the same practice, and the importance of users taking turns. 616 
‘At this facility, the health workers are very tough on those who come later and 617 
want to be worked on first through skipping the queue. When one does that, the 618 
health workers can punish by working on you last’’, (user #13, a 47-year-old female 619 
with HIV at facility C, first round of interviews)  620 
 621 
Efficiency of services after the establishment of the HIV/NCD integrated clinic  622 
The users attributed the acceptability of the integrated HIV/NCD clinic to the continued 623 
observation of the `first come first serve’ principle. The users explained that this continued 624 
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practice, where someone who came later could not jump the queue, improved acceptability of 625 
the integrated HIV/NCD clinics.  626 
 “Creating awareness through health education and secondly we serve them as they 627 
come, we do first come first serve unless it is an emergency which we inform other 628 
patients about”, (HCW participant #4, a 28-year-old female clinician at facility D, 629 
second round of interviews).  630 
During the second and third round of interviews, most of the diabetes and hypertension users 631 
reported that the integrated clinic was acceptable to them as drugs/diagnostics shortages had 632 
become rare and the service was more efficient.  633 
 “Whenever I come to pick my drugs, the health workers are available and ready to 634 
attend to all at all the serving points I go through till to the point of picking up the 635 
drugs. I have never faced any problem ever since I joined this facility’’, (user #19, 636 
a 32-year-old female with NCD at facility A, third round of interviews). 637 
As noted above, changes were beginning to creep in as MOCCA was coming to an end.  Some 638 
drugs were beginning to run out.  639 
“the quality hasn’t been bad, it is just that at times there are no drugs or if you are 640 
to get 2 types of drugs you will find that you have only gotten one type and the 641 
other type is not available yet you will have spent so much time waiting for drugs 642 
just to be told that the drugs are not available’’, (user #17, a 46-year-old male with 643 
NCD at facility C, third round of interviews). 644 
 645 
Length of waiting time before the HIV/NCD integrated clinic establishment 646 
Most users reported that they spent a lot of time at the health facility each time they went for 647 
either a review or a drug refill prior to the establishment of the HIV/NCD integrated clinic. The 648 
users explained that most delay was at the consultation and the dispensing sections of the care 649 
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pathway. The users further attributed the long waiting time to the fact that HCWs were faced 650 
with many patients to attend to. The majority of the HCWs agreed with this view. 651 
‘…the number of patients attending the hypertension and diabetes clinic is so high 652 
yet we are few in number. The patients end up spending many hours at the facility’, 653 
(HCW participant # 5, a 54-year-old female nursing assistant at facility D, first 654 
round of interviews) 655 
Some users attributed the long waiting time to the fact that some HCWs reported late for work 656 
so there was a backlog of people to be seen throughout the day.  657 
 658 
Length of waiting time after the establishment of the HIV/NCD integrated clinic  659 
Most care users reported that with the introduction of the integrated clinic, their service waiting 660 
time had greatly reduced. They explained that users accessing care through the integrated clinic 661 
were often prioritised first when they went to the laboratory and at the dispensing window.  662 
“I don’t feel delayed at all. The care providers always attend to me [and] worked 663 
on me the moment I set foot in the facility, they also always give me a call 664 
reminding me to come to the facility a day prior to my appointment. It is something 665 
very unique about these health care providers. We follow the queue same way we 666 
came in. if you came in earliest in the morning, then you leave earlier than any 667 
other patients”, (user #4, a 60-year-old female with NCD and HIV at facility B, 668 
third round of interviews).  669 
 670 
Sitting arrangements before the HIV/NCD clinic integration 671 
Almost all the users prior to the HIV/NCD integrated clinic establishment reported that their 672 
sitting arrangement was arranged by the HCWs, but within the designated area  users were free 673 
to sit anywhere. They enjoyed sitting with their friends as they waited to be served. Among the 674 
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things they discussed as they waited for the service were treatment side effects, adherence, 675 
dietary requirements and service access challenges to mention but a few.  676 
‘there is no problem with the sitting arrangement. Everyone is free to sit anywhere with 677 
his/her friends and the queue to the consultation room is strictly observed’, (participant 678 
8, a 59-year-old female with HIV at facility A, first round of interviews). 679 
 680 
Sitting arrangements after the establishment of the HIV/NCD integrated clinic   681 
Most users reported that they were comfortable with the sitting arrangements under the 682 
integrated clinic. The users explained that although the HCWs organised these sitting 683 
arrangements, the people attending the facility were free to sit anywhere. The queue to consult 684 
the HCW in a particular order (first come first served) was still observed. The users explained 685 
that with the freedom to sit anywhere, they were still able to sit with their friends.  686 
 “I am comfortable […]. The chairs are enough and the place is not very crowded 687 
and when I come, I sit where I find a free seat”, (participant 23, a 39-year-old 688 
female with HIV at facility D, third round of interviews).  689 
 690 
Number of visits to the clinic before HIV/NCD integration 691 
Prior to the establishment of the integrated clinic, most users with multi-morbidities reported 692 
that they were making more frequent visits to the health facilities to seek care for a single 693 
condition. The only exception was the users with multi-morbidities attending facility E where 694 
less severe hypertension and diabetes care needs were handled jointly with HIV. However, 695 
even from there the severe hypertension and diabetes care needs were referred to the nearby 696 
national referral hospital.  697 
‘People like me with more than one condition, have to come to the facility on 698 
Tuesday for HIV and also come back on Thursday for hypertension within the same 699 
33 
 
week. The clinic day for HIV is Tuesday while that of hypertension is Thursday. If 700 
you have both conditions, you visit the facility two times a week’, (participant 3, a 701 
37-year-old female with HIV at facility D, first round of interviews). 702 
 703 
Number of visits after the HIV/NCD clinic integration 704 
In the second and third phases of data collection, all the users reported that the integrated clinic 705 
was acceptable to them because it had indeed helped reduce their number of visits. This saved 706 
them transport money and time.  707 
 “One of the good things I have got from the integration is that, once someone is 708 
not doing fine, one gets free information on what to do, I get to know about the 709 
nutrition I am supposed to use for my better health. The integration has also reduced 710 
the amount of money and time that I use at the facility since I no longer spend any 711 
more money going to other facilities to pick drugs”, (user #29, a 63-year-old male 712 
with NCD and HIV at facility A, third round of interviews).  713 
The HCWs reported that while having a single treatment visit was a good practice for  users, it 714 
made more work for them.  715 
 “We treat patients with co-morbidities on one single visit because of the 716 
integration but there is a lot of paperwork, there is a lot of screening and taking off 717 
people’s blood always, taking pulse, filling cards, opening up files for clients”, 718 
(HCW participant #9, a 34-year-old male clinician, at facility C, third round of 719 
interviews).  720 
Overall, the integrated clinic model resulted in services being accessible to HIV, hypertensive 721 
and diabetic users alike.  While integration was blamed for an increased workload by some 722 





Our findings show that the integrated HIV, diabetic and hypertensive care delivery model 726 
improved diabetic and hypertensive care availability without compromising the provision of 727 
HIV care. Costs of transport were reduced for users, who were able to access care for more 728 
than one condition at a single visit.  Users remarked that everyone looked the same in the 729 
waiting area, so in most clinics it was impossible to distinguish people seeking HIV care from 730 
those accessing care for diabetes or hypertension.  We also found that integration helped to 731 
make hypertension and diabetes care more affordable by ensuring drugs were available for 732 
those conditions, and users did not have to meet prescription costs themselves.   733 
In MOCCA the improvement in drug and diagnostics supply and availability was key to the 734 
acceptability of the integrated service. However, providing integrated care could not eradicate 735 
all the costs related to treatment, such as the costs of transport, and also food stuff which users 736 
said they needed to support treatment adherence, a finding corroborated in other studies (26, 737 
46, 47).  Cost has been shown to be a significant in impeding access to and retention in NCD 738 
care in Africa.  A study in eastern Uganda among  users with  an NCD showed that over 92% 739 
of the diabetic users were unable to afford drugs purchases and this increased their rates of 740 
multi-morbidity (48). Other research showed that NCD users in Uganda were found to be 741 
unable to afford the cost of care  (49) and faced significant geographical constraints to 742 
accessing services (50, 51). In South Africa, Malawi, Kenya and Uganda transport difficulties 743 
remained a key component not only in the integrated non-communicable diseases care but also 744 
for general health care access (7, 51-56).  We found in our study that even when the number of 745 
clinic visits were reduced, some people still struggled to meet the costs of transport to get to 746 
their appointments. 747 
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The challenges related to access, particularly costs, faced by users prior to MOCCA were not 748 
unusual in the region. The establishment of integrated clinics – one stop shops - providing both 749 
for people living with HIV, and people with an NCD who do not require HIV care, faces 750 
multiple challenges, such as in ensuring an NCD drug supply chain, establishing sustainable 751 
referral systems, ensuring adequately trained staff and providing monitoring across a range of 752 
different conditions (57-59). In South Africa, a third of the hypertensive service users attending 753 
primary healthcare facilities could not access their prescribed drugs due to drug unavailability 754 
(23, 60, 61). The provision of functional diagnostic equipment  is needed to ensure that no users 755 
are asked to finance further investigations out of pocket or purchase drugs from private 756 
pharmacies (62). Drug shortages and lack of diagnostic equipment negatively affected the 757 
service availability, with evidence from a number of studies showing that the provision of 758 
integrated care and management calls for a clear strategy to support a well organised health 759 
system in a supportive political environment for optimal outcomes (23, 49, 63-65).  As Kasaie, 760 
Weir (13) observe, for integration to be successful increased financial commitment is required 761 
to support and sustain services, particularly if they are to be delivered at scale.  A review of 762 
health care policies in East Africa showed that in Uganda, Kenya, Tanzania and Rwanda, that 763 
while steps had been taken to change policy and practice to integrate NCD care into HIV care 764 
in the region, with some success, there were still challenges in sustaining integrated care (21).  765 
Evidence from elsewhere has highlighted that a poor HCW-patient relationship, long queues, 766 
as well as stigma are barriers to integrated chronic disease care  acceptability (23, 25, 51, 65, 767 
66).  Our study findings on stigma corroborate those of research in South Africa where 768 
integrated care helped to reduce stigma among the people living with HIV (23, 51), although 769 
we found that this was not necessarily the case for younger people, who feared that they could 770 
be identified as someone with HIV because they were too young to have an NCD.   771 
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Studies in rural Kenya and South Africa have reported that being dissatisfied with the treatment 772 
was one of the reasons why hypertensive, diabetic and HIV service users skipped refill 773 
appointments (55, 63). Ensuring quality care, is important to acceptability in any type of clinic. 774 
Where good care is provided, or where care is perceived to be of better quality to that provided 775 
prior to integration, users are less likely to be dissatisfied. A study in Malawi showed that 776 
NCD-HIV care integration increased NCD service users’ enrolment upon care integration 777 
resulting in similar retention levels for hypertension, diabetes and HIV as well as favourable 778 
clinical outcomes (67). Other factors also play a part in maintaining access to care.  Studies 779 
from rural Uganda and South Africa among hypertensive service users and HIV positive 780 
postpartum women respectively reported that having a supportive family and accessible health 781 
facilities promoted care acceptability (54, 56); these are areas of support which go beyond the 782 
establishment of integrated clinics, but can be important in helping people stay in care.  783 
 784 
Strengths and limitations 785 
The key strength of this study lies in the longitudinal design that allowed us to observe and 786 
document user and HCW perceptions and experiences of integrated clinics at different points. 787 
It is the first study of its kind in Uganda evaluating a one-stop clinic where people with any 788 
one or more of the chronic conditions (HIV, diabetes and hypertension) can attend. Another 789 
strength lies in our ability to triangulate perspectives of both those receiving integrated care 790 
and those providing care. We investigated the  users’ and health care providers’ perceptions 791 
and experiences of an integrated care delivery model using multiple data sources which were 792 
triangulated across sources (patients and providers) and methods (interview and observation). 793 
Other strengths include: the diverse range of health facility type and level and the different 794 
levels of integration at each of the facilities included in this study. Limitations centred on the 795 
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difference across facilities in terms of the level and type of healthcare services offered and/or 796 
integration. Also, we recognise that MOCCA as feasibility study provided drugs and diagnostic 797 
support which covered shortages in NCD durgs. We therefore do not know how available, 798 
affordable and acceptable the integrated HIV/NCD health care delivery model would be 799 
without this support.  800 
  801 
Conclusion  802 
Our study findings illustrate the key components of successful and acceptable integration from 803 
the perspectives of health care users and providers in a Ugandan setting. We show that 804 
integration is popular with people who have multiple conditions as accessing care in vertical 805 
clinics is expensive in time and money.  For people with a single condition, an integrated clinic 806 
providing good care, with a secure drug supply, is also attractive. A successful integrated health 807 
care delivery model calls for political will to ensure investment in the health system to 808 
standardise drug, reagent and diagnostic equipment supply. This investment needs to be 809 
accompanied with clinic-user health education to encourage early linkage to care, and the 810 
importance of staying in care, as well as to increase understanding of different conditions to 811 
reduce stigma.  812 
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